Compared with other tumor types, the TIME of SCLC is affected by low PD-L1 expression, insufficient MHC molecules expression, and dysregulated expression of cluster differentiation antigens, which leads to reduced immunogenicity, decreased TILs, and decreased antigen presentation to TILs, especially CD8+ T cells. Here, CD8A is linked to neoplasm.